What is Alice?
Alice operates at the intersection of health insurance and coordinated medical care, utilizing a data-driven approach to redefine the patient experience. Unlike traditional models that prioritize reactive treatment, Alice emphasizes proactive, personalized, and continuous health management. The company's platform integrates comprehensive health-plan coverage with a sophisticated care model, enabling members to navigate primary care, specialist consultations, and diagnostic services with unprecedented efficiency. By leveraging technology to streamline healthcare delivery, Alice is effectively shifting the paradigm of medical services in Brazil, moving toward a model that prioritizes long-term wellness and preventative care over episodic intervention.
How much funding has Alice raised?
Alice has raised a total of $300M across 3 funding rounds:
Unspecified
$33M
Series C
$127M
Series D
$140M
Unspecified (2021): $33M with participation from ThornTree Capital Partners
Series C (2021): $127M led by The Stepstone Group, Softbank, G Squared, Allen & Company, and Globo Ventures
Series D (2026): $140M supported by Phoenix Insurance, Vintage Investment Partners, Apax Digital, Norwest, MoreTech VC, SentinelOne, Highland Europe, Maj Invest, Crv, and Samsung
Key Investors in Alice
Norwest
Norwest is a global venture and growth equity investment firm with over $15.5 billion in capital, dedicated to helping CEOs and founders scale their businesses across various sectors including biotech and fintech.
Highland Europe
Highland Europe provides growth capital to exceptional teams, focusing on product-led companies across software and consumer sectors with over $3 billion in assets under management.
Vintage Investment Partners
Vintage Investment Partners is a trusted partner with over $3.6 billion in assets, leveraging a proprietary database of over 21,400 investors to deliver invaluable insights and strategic connections.
What's next for Alice?
With the successful completion of this major enterprise-level funding round, Alice is well-positioned to accelerate its operational scaling and technological development. The influx of capital will likely be directed toward enhancing its proprietary data management systems and expanding its coordinated care network to reach a broader demographic. As the company matures, the focus will remain on deepening its integration with hospital partners and refining its predictive health analytics to further improve patient outcomes. This strategic growth phase underscores Alice's commitment to long-term sustainability and its ambition to set a new standard for integrated healthcare delivery in the region.
See full Alice company page
